These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 12394164

  • 1. Proper usage of pancreatic enzymes.
    Schibli S, Durie PR, Tullis ED.
    Curr Opin Pulm Med; 2002 Nov; 8(6):542-6. PubMed ID: 12394164
    [Abstract] [Full Text] [Related]

  • 2. Fibrosing colonopathy in cystic fibrosis.
    Smyth RL.
    Arch Dis Child; 1996 May; 74(5):464-8. PubMed ID: 8669970
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cystic fibrosis colonopathy.
    Lloyd-Still JD, Beno DW, Kimura RM.
    Curr Gastroenterol Rep; 1999 Jun; 1(3):231-7. PubMed ID: 10980955
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fibrosing colonopathy in an adult caused by over use of pancreatic enzyme supplements.
    Häusler M, Heimann G, Meilcke R, Biesterfeld S.
    Gut; 2000 Oct; 47(4):598. PubMed ID: 11203308
    [No Abstract] [Full Text] [Related]

  • 8. Fibrosing colonopathy in cystic fibrosis: results of a case-control study.
    Smyth RL, Ashby D, O'Hea U, Burrows E, Lewis P, van Velzen D, Dodge JA.
    Lancet; 1995 Nov 11; 346(8985):1247-51. PubMed ID: 7475715
    [Abstract] [Full Text] [Related]

  • 9. Cystic fibrosis with fibrosing colonopathy in the absence of pancreatic enzymes.
    Waters BL.
    Pediatr Dev Pathol; 1998 Nov 11; 1(1):74-8. PubMed ID: 10463274
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.
    FitzSimmons SC, Burkhart GA, Borowitz D, Grand RJ, Hammerstrom T, Durie PR, Lloyd-Still JD, Lowenfels AB.
    N Engl J Med; 1997 May 01; 336(18):1283-9. PubMed ID: 9113931
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Symptomatic increase in intracranial pressure following pancreatic enzyme replacement therapy for cystic fibrosis.
    Nasr SZ, Schaffert D.
    Pediatr Pulmonol; 1995 Jun 01; 19(6):396-7. PubMed ID: 7567222
    [Abstract] [Full Text] [Related]

  • 14. Colonic wall thickness, pancreatic enzyme dose and type of preparation in cystic fibrosis.
    Ramsden WH, Moya EF, Littlewood JM.
    Arch Dis Child; 1998 Oct 01; 79(4):339-43. PubMed ID: 9875045
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Fibrosing colonopathy in a child on low-dose pancreatin.
    Taylor CJ, Steiner GM.
    Lancet; 1995 Oct 21; 346(8982):1106-7. PubMed ID: 7564819
    [No Abstract] [Full Text] [Related]

  • 17. Colonic wall thickening is related to age and not dose of high strength pancreatin microspheres in children with cystic fibrosis.
    Connett GJ, Lucas JS, Atchley JT, Fairhurst JJ, Rolles CJ.
    Eur J Gastroenterol Hepatol; 1999 Feb 21; 11(2):181-3. PubMed ID: 10102230
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.